Reuben A et al The use of tranexamic acid to reduce the need for nasal packing in epistaxis (NoPac): Randomised Controlled Trial (accepted 18.12.2020 for publication in Annals of Emergency Medicine)
Articles
Taylor A (2023) 'Effectiveness and cost-effectiveness of behavioural support for prolonged abstinence for smokers wishing to reduce but not quit: Randomised controlled Trial of physical Activity assisted Reduction of Smoking (TARS)' Addiction ,
DOI Open access
Rapson R, Marsden J, Latour J, Ingram W, Stevens KN, Cocking L & Carter B (2022) 'Multicentre, randomised controlled feasibility study to compare a 10-week physiotherapy programme using an interactive exercise training device to improve walking and balance, to usual care of children with cerebral palsy aged 4–18 years: the ACCEPT study protocol' BMJ Open 12, (5) ,
DOI Open access
Reuben A, Appelboam A, Stevens KN, Vickery J, Ewings P, Ingram W, Jeffery AN, Body R, Hilton M & Coppell J (2021) 'The Use of Tranexamic Acid to Reduce the Need for Nasal Packing in Epistaxis (NoPAC): Randomized Controlled Trial' Annals of Emergency Medicine ,
DOI Open access
Taylor A, Thompson TP, Ussher M, Aveyard P, Murray RL, Harris T, Creanor S, Green C, Streeter AJ & Chynoweth J (2020) 'Randomised controlled trial of tailored support to increase physical activity and reduce smoking in smokers not immediately ready to quit: protocol for the Trial of physical Activity-assisted Reduction of Smoking (TARS) Study' BMJ OPEN 10, (12) Author Site Publisher Site ,
DOI Open access
Taylor A, Taylor RS, Ingram W, Dean SG, Jolly K, Mutrie N, Lambert J, Yardley L, Streeter A & Greaves C (2020) 'Randomised controlled trial of an augmented exercise referral scheme using web-based behavioural support for inactive adults with chronic health conditions: the e-coachER trial' Br J Sports Med Author Site Publisher Site Open access
Taylor AH, Taylor RS, Ingram WM, Anokye N, Dean S, Jolly K, Mutrie N, Lambert J, Yardley L & Greaves C (2020) 'Adding web-based behavioural support to exercise referral schemes for inactive adults with chronic health conditions: the e-coachER RCT' Health Technology Assessment 24, (63) 1-106 ,
DOI Open access
Nyman SR, Ingram W, Sanders J, Thomas PW, Thomas S, Vassallo M, Raftery J, Bibi I & Barrado-Martín Y (2019) 'Randomised Controlled Trial Of The Effect Of Tai Chi On Postural Balance Of People With Dementia' Clinical Interventions in Aging Volume 14, 2017-2029 ,
DOI Open access
Nyman SR, Hayward C, Ingram W, Thomas P, Thomas S, Vassallo M, Raftery J, Allen H & Barrado-Martín Y (2018) 'A randomised controlled trial comparing the effectiveness of tai chi alongside usual care with usual care alone on the postural balance of community-dwelling people with dementia: protocol for the TACIT trial (TAi ChI for people with demenTia)' BMC Geriatrics 18, (1) 263-263 Author Site ,
DOI Open access
Ingram W, Webb D, Taylor RS, Anokye N, Yardley L, Jolly K, Mutrie N, Campbell JL, Dean SG & Greaves C (2018) 'Multicentred randomised controlled trial of an augmented exercise referral scheme using web-based behavioural support in individuals with metabolic, musculoskeletal and mental health conditions: protocol for the e-coachER trial' BMJ Open 8, (9) Author Site ,
DOI Open access
Ukoumunne OC, Vaidya B, Frost J, Anderson R, Argyle C, Daly M, Harris-Golesworthy F, Harris J, Gibson A & Ingram W (2017) 'A preconsultation web-based tool to generate an agenda for discussion in diabetes outpatient clinics to improve patient outcomes (DIAT): a feasibility study' BMJ Open 7, (3) ,
DOI Open access
Frost J, Anderson R, Argyle C, Daly M, Harris-Golesworthy F, Harris J, Gibson A, Ingram W, Pinkney J & Ukoumunne OC (2013) 'A pilot randomised controlled trial of a preconsultation web-based intervention to improve the care quality and clinical outcomes of diabetes outpatients (DIAT)' BMJ Open 3, (7) e003396-e003396 ,
DOI Open access
Freeman J, Walters R, Ingram W, Slade A, Hobart J & Zajicek J (2013) 'Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures' Mult Scler 19, (12) 1632-1639 Author Site ,
DOI
(2011) 'Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis' Nature 476, (7359) 214-219 ,
DOI Open access
Zajicek JP, Ingram WM, Vickery J, Creanor S, Wright DE & Hobart JC (2010) 'Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort' BMC Neurol 10, Author Site ,
DOI Open access
Ingram WM, Priston MJ & Sewell GJ (2006) 'Improved assay for R(-)-apomorphine with application to clinical pharmacokinetic studies in Parkinson's disease' J Chromatogr B Analyt Technol Biomed Life Sci 831, (1-2) 1-7 Author Site ,
DOI
Hobart JC, Riazi A, Thompson AJ, Styles IM, Ingram W, Vickery PJ, Warner M, Fox PJ & Zajicek JP (2006) 'Getting the measure of spasticity in MS: The Multiple Sclerosis Spasticity Scale (MSSS-88)' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Baron R, Ingram W, Warner M, Vickery PJ, Wright DE, Zajicek J & Hobart JC (2006) 'Meaningless statistics and the illusion of fatigue' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ & Thompson AJ (2005) 'Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up' J Neurol Neurosurg Psychiatry 76, (12) 1664-1669 Author Site ,
DOI
Hobart, Riazi A, Styles IM & Thompson AJ (2005) 'Getting the measure of spasticity in Multiple Sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS - 89)' Brain 129, (1) 224-234 ,
DOI
Baron R, Zajicek J, Wright D, Vickery J, Ingram W & Hobart J (2005) 'Confounding the confused: is measuring the frequency and severity of cognitive impairment really necessary?' Multiple Sclerosis 11, S68-S68
Hobart JC, Riazi A, Thompson AJ, Styles IM, Ingram W, Vickery PJ, Warner M, Fox PJ & Zajicek JP (2005) 'Getting the measure of spasticity in MS: The Multiple Sclerosis Spasticity Scale (MSSS-88)' Journal of the Neurological Sciences 238, S229-S229
Zajicek J, Fox R, Teare L, Sanders H, Wright D, Vickery J, Ingram W, Reilly S, Nunn A & Thompson A (2004) 'Cannabinoids in multiple sclerosis (CAMS) study, follow-up data suggesting an effect on disease progression' Journal of Neurology 251, 44-44
Ingram WM, Priston MJ & Sewell GJ (1999) 'Dose optimisation for amorphine in Parkinson's disease: Pharmacokinetic-pharmacodynamic (PK-PD) studies' Journal of Pharmacy and Pharmacology 51, (SUPPL.)